Search for Clinical Trial Results

Sponsored By

Lymphoma, Large-Cell, Immunoblastic - 25 Studies Found

Status Study
Completed Study Name: Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Condition:
  • Lymphoma, Non-Hodgkin
  • HIV Infections

Date: 1999-11-02
Interventions:
  • Drug: Mitoxantrone hydrochloride
  • Drug: Eto
Active, not recruiting Study Name: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Condition:
  • Burkitt Lymphoma
  • Diffuse Large B-cell Lymphoma, c-MYC Positive
  • Drug: EPOCH-R EPOCH-R every 21
Completed Study Name: Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)
Condition:
  • Lymphoma, B-Cell
  • Lymphoma, Large-Cell, Immunoblastic
  • Date: 2006-05-22
    Interventions:
    • Drug: Autologous transplantation using rituxan/BEAM

Completed Study Name: Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Condition:
  • AIDS-related Diffuse Large Cell Lymphoma
  • AIDS-related Immunoblastic La
    Date: 2002-11-12
    Interventions:
    • Biological: rituximab Given IV
Recruiting Study Name: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
Condition:
  • AIDS-related Non-Hodgkin Lymphoma
  • AIDS-related Plasmablastic Lymphoma<
    Date: 2013-09-09
    Interventions:
    • Drug: busulfan Given IV

Completed Study Name: Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Condition: Lymphoma
Date: 1999-11-01
Interventions:
  • Biological: bleomycin sulfate
  • Drug: CHOP r
Completed Study Name: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma
Condition: Untreated T-cell Angioimmunoblastic Lymphoma
Date: 2005-09-12
Interventions:
  • Drug: Rituximab 375 mg/m2 D1
Not yet recruiting Study Name: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Burkitt Lymphoma
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D
    Date: 2015-05-26
    Interventions:
    • Drug: Cyclophosphamide Given I
Active, not recruiting Study Name: Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Condition:
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Previously Treated Myelodysplast
    Date: 2005-03-03
    Interventions:
    • Drug: Fludarabine Phosphate Gi
Completed Study Name: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Undifferentiated Leukemia
  • Date: 2005-06-02
    Interventions:
    • Drug: fludarabine phosphate Gi
Next >>>